Migraine: Dynamics of psychophysiologic pattern

Zhurnal Nevropatolgii i Psikhiatrii im. S S Korsakova

Volumn 100, Issue 12, 2000, Pages 13-20

  Vein, A M ^a   Danilov, A B ^a   Kolosova, O A ^a   Voznesenskaya, T G ^a   Levin, Ya I ^a   Tabeeva, G R ^a   Khaspekova, N B ^a   Danilov, Al B ^a   Chernyshev, O Yu ^a   Sinyachkin, M S ^a   Vornovskaya, O V ^a   Fokin, I V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE;

ANXIETY; EVOKED RESPONSE; HOSPITALIZATION; HUMAN; METABOLISM; MIGRAINE; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYSOMNOGRAPHY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REM SLEEP; REVIEW; TRIGEMINAL NERVE;

ANXIETY; CATECHOLAMINES; EVOKED POTENTIALS; HUMANS; MIGRAINE DISORDERS; POLYSOMNOGRAPHY; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SLEEP, REM; TRIGEMINAL NERVE;

EID: 0034566018     PISSN: 00444588     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Afra J., Mascia A., Gerard P., Maertens de Noordhout A., Schoenen J. Interictal cortical excitability in migraine: a study using transcranial magnetic stimulation of motor and visual cortices. Ann Neurol 1998; 44: 2: 209-215.
2. Bednarczyk E.M., Remler B., Weikart C., Nelson A.D., Reed R.C. Global cerebral blood flow, blood volume, and oxygen metabolism in patients with migraine headache. Neurology 1998; 50: 1736-1740.
3. Birbaumer N., Elbert T., Canavan A., Rockstroh B. Slow potentials of the cerebral cortex and behavior. Physiol Rev 1990; 70: 1-41.
4. Buzzi M.G., Moskowitz M.A. The trigemino-vascular system and migraine. Path Biol (Paris) 1992; 40: 4: 313-317.
5. Danilov A.B., Vein A.M., Voznesenskaya T.G. Central action of aspirin: CNV and RIII data in healthy volunteers and migraine patients. Abstract book of 8th Congress of the International Headache Society. Amsterdam 1997.
6. Evers S., Quibeldey F., Grotemeyer K.H., Suhr B., Husstedt I.W. Dynamic changes of cognitive habituation and serotonin metabolism during the migraine interval. Cephalalgia 1999; 19: 5: 485-491.
7. Ferrari M.D. Migraine. Lancet 1998; 4: 351: 9108:1043-1051.
8. Gerber W.D., Schoenen J. Biobehavioral correlates in migraine: the role of hyper-sensitivity and information-processing dysfunction. Cephalalgia 1998; 18: 21: 5-11.
9. Kohler T. Zur Psychophysiologie der Migraene. Verhaltenstherapie und Verhaltensmedizin 1999; 20: 305-320.
10. Kolosova O.A. Influence of Aspisol on CNV during migraine attack. Cephalalgia 1997; 17: 3: 380-381.
11. Kropp P., Gerber W.D. Contingent negative variation - findings and perspectives in migraine. Cephalalgia 1993; 13: 33-36.
12. Kropp P., Gerber D. Is increased amplitude of contingent negative variation in migraine due to cortical hyperactivity or to reduced habituation? Cephalalgia 1993; 13: 37-41.
13. Kropp P., Gerber W.D. Prediction of migraine attacks using a slow cortical potential, the contingent negative variation. Neurosci Lett 1998; 27: 257: 2: 73-76.
14. Mascia A., Afra J., Schoenen J. Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data. Cephalalgia 1998; 18: 174-182.
15. McCallum W.C. Potentials Related to Expectancy, Preparation and Motor Activity. Human Event-related Potentials. T.W. Picton (ed.). EEG Handbook, Elsevier Science Publishers 1988; 3: 427-534.
16. McGiunness D., Pribam K. The neuropsychology of attention: emotional and motivational control. Academic Press 1980.
17. 99mTc HMPAO studies in migraine patients. Acta Neurol Belg 1998; 98: 190-194.
18. Mosnaim A.D., Kulaga H., Adams A.J., Wolf M.E., Puente J., Freitag F., Diamond S. Flow cytometric analysis of lymphocyte subsets in migraine patients during and outside of an acute headache attack. Cephalalgia 1998; 18: 197-201.
19. Nagel-Leiby S., Welch K.M.A., D'Andrea G., Grunfeld S., Brown E. Event-related slow potentials and associated catecholamine function in migraine. Cephalalgia 1990; 10: 317-329.
20. Olesen J. Migraine. Proc. 5th Int. Migraine Symp. London 1985; 130-137.
21. Pfaffenrath V., Gerber W.D. Chronische Kopfschmerzen. Stuttgart 1992; 242.
22. Roemer R.A., Shagass C., Teyler T.J. Do human evoked potentials habituate? H.V. Peeke, L. Petrinovich (eds.). Habituation, Sensitization and Behavior. NY: Academic Press, 1984; 325-346.
23. Rohrbaugh W.J., Gaillard A.G. Sensory and motor aspects of the contingent negative variation. Tutorials in event-related potential research. A.G. Gaillard, W. Ritter (eds.). Endogenous components. Amsterdam: Elsevier 1983: 269-310.
24. Siniatchkin M., Gerber W.D., Kropp P., Vein A. How the brain anticipates an attack: a study of neurophysiological periodicity in migraine. Funct Neurol 1999; 14: 2: 69-77.
25. Siniatchkin M., Gerber W.D., Kropp P., Voznesenskaya T.G., Vein A. Are the periodic changes of neurophysiological parameters during the pain-free interval in migraine related to abnormal orienting activity? Cephalalgia 2000; 20: 1: 20-29.
26. Siniatchkin M., Kropp P., Gerber W.D. Migraine in childhood: are periodically occuring migraine attacks related to dynamic changes of cortical information processing? Neurosci Lett 2000; 21: 279: 1: 1-4 (in press).
27. Terwindt G.M., Ophoff R.A., Haan J., Sandkuijl L.A., Frants R.R., Ferrari M.D. Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies. Dutch Migraine Genetics Research Group. Eur J Hum Genet 1998; 6: 4: 297-307.
28. Vein A., Voznesenskaya T., Danilov A.B. The effects of aspirin on the CNV in healthy individuals. Cephalalgia 1995; 15: 2: 129-131.
29. Vein A.M., Voznesenskaya T.G., Danilov A.B. Influence of aspirin on the contingent negative wave in healthy subjects. Neurosci Behav Psychiol 1996; 26: 5: 489-491.
30. Vein A.M., Danilov A.B., Kolosova O.A., Tchernychev O.Y. Aspirin and trigeminal evoked potentials in migraine. Funct Neurol 1998; 13: 2: 199.